Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LEXX

Recent news which mentions LEXX

< Previous 1 2 3 4 Next >
Lexaria Bioscience (NASDAQ: LEXX) Issues Update On Human Nicotine Study
Tickers LEXX LEXXW
Tags LEXXW Partner Content Penny Stocks
From Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Begins Nicotine Formulation Creation, Evaluation Program
Tickers LEXX
Tags Market News Benzinga General
From Benzinga
Lexaria Aims To Demonstrate DehydraTECH's Performance In Epilepsy Research
Tickers LEXX
Tags Market News Benzinga General
From Benzinga
Lexaria Bioscience's 24th Patent Sets Stage For Market Opportunities In Australia
Tickers LEXX
Tags Market News Benzinga General
From Benzinga
Lexaria Bioscience Optimistic About Upcoming Hypertension Study
Tickers LEXX
Tags Partner Content LEXX Penny Stocks
From Benzinga
Lexaria's IP Portfolio Grows Following Receipt Of 24th Granted Patent
Tickers LEXX
Tags LEXX Penny Stocks Partner Content
From Benzinga
Lexaria Bioscience Commences DehydraTECH-CBD Epilepsy Research Program
Tickers LEXX LEXXW
Tags LEXX Penny Stocks Partner Content
From Benzinga
Lexaria Bioscience Receives Award For Oral Nicotine Compound Patent
Tickers LEXX
Tags Benzinga Market News Biotech
From Benzinga
Studies Advance Lexaria Bioscience's Tech For Improving Pharmaceutical Drugs
Tickers LEXX
Tags Penny Stocks LEXX Partner Content
From Benzinga
Lexaria's DehydraTECH(TM) Demonstrates Faster Delivery Of Sildenafil
Tickers LEXX TM
Tags Partner Content Penny Stocks LEXX
From Benzinga
Lexaria Bioscience Optimistic Of Positive Study Results
Tickers LEXX
Tags InvestorBrandNetwork Market News Benzinga
From Benzinga
Lexaria Optimistic About Expanded DehydraTECH Investigations
Tickers LEXX
Tags Benzinga Market News Biotech
From Benzinga
Lexaria World Leader Through DehydraTECH(TM) – Its Pioneering Drug Delivery Tech
Tickers LEXX TM
Tags Markets Partner Content Penny Stocks
From Benzinga
Following Sildenafil Study, Lexaria Announces Plans For More Studies In 2022
Tickers LEXX
Tags Partner Content LEXX Penny Stocks
From Benzinga
Lexaria's DehydraTECH(TM) To Be Evaluated As Treatment For Multiple Conditions
Tickers LEXX TM
Tags Penny Stocks LEXX Partner Content
From Benzinga
Lexaria Technology Shows Promise In Improving Performance Of ED Drugs
Tickers LEXX
Tags LEXX Penny Stocks Partner Content
From Benzinga
Lexaria CEO Summarizes 2021 Milestones in Letter to Shareholders
Tickers LEXX
Tags Benzinga Market News Biotech
From Benzinga
Lexaria Bioscience Announces Significant Findings From Sildenafil Animal Study
Tickers LEXX
Tags LEXX Penny Stocks Partner Content
From Benzinga
Lexaria CEO Offers A Glimpse Into Company's Unique Tech On EDGE Podcast
Tickers LEXX
Tags Penny Stocks LEXX Partner Content
From Benzinga
Lexaria Emphasizes Oral Cannabinoid Benefits Following SARS-CoV-2 Study
Tickers LEXX
Tags InvestorBrandNetwork Benzinga Market News
From Benzinga
Lexaria Bioscience Marks Great Start to its 2022 R&D Programs
Tickers LEXX
Tags News General Penny Stocks
From Benzinga
Lexaria Bioscience Comments on Study Examining Cannabinoids and SARS-CoV-2
Tickers LEXX
Tags Penny Stocks Cannabis LEXX
From Benzinga
Lexaria Bioscience Leveraging DehydraTECH(TM) for More Effective Oral Medicine
Tickers LEXX TM
Tags LEXX Penny Stocks Partner Content
From Benzinga
Lexaria Bioscience Celebrates Productive Year for Blood Pressure Drug Solution
Tickers LEXX
Tags Markets Partner Content Penny Stocks
From Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Receives Independent Review Board Approval for Human Study
Tickers LEXX
Tags Market News Benzinga General
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ATOS AXSM CFRX ENSC
Tags BZI/TFM LEXX RSLS
From Benzinga
Lexaria Bioscience Increases Investor Visibility with SRAX
Tickers LEXX SRAX
Tags LEXX Penny Stocks Partner Content
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Tickers ATOS BVXV CEMI CFRX
Tags BZI/TFM LEXX Market News
From Benzinga
Lexaria Bioscience Announces Approval from Independent Review for DehydraTECH-CBD Study
Tickers LEXX
Tags InvestorBrandNetwork General Biotech
From Benzinga
Lexaria Bioscience Expects Study Results to Show Patented Tech's Value in Treating Hypertension
Tickers LEXX
Tags LEXX Penny Stocks Partner Content
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.